Roberta Brinton, PhD, director of the Center for Innovation in Brain Science, received a $15.1 million grant from the National Institutes on Aging to investigate perimenopausal brain aging.

As interest grows around COVID-19 booster shots, there is still a lot of uncertainty around getting a third dose. People with weakened immune systems can already get a booster, but the benefit to everyone else is unclear. Deepta Bhattacharya, PhD, a professor of immunobiology at the College of Medicine – Tucson, said that it's clear a booster could be beneficial. A booster, he said, might reduce the chance that a person would get infected and develop symptoms. What's less clear is how much a national booster strategy would help control the spread of the coronavirus. "It just doesn't seem like vaccinated breakthrough infections are the major source of transmission," he said.

The complexity of the body’s immune system makes the impact of a booster shot difficult to assess. Antibody levels from any vaccine or natural infection will decline over time, says Deepta Bhattacharya, PhD, an immunologist at the College of Medicine – Tucson. Yet “the ones that are left tend to be of higher quality, so it takes far fewer of them to protect against disease,” Bhattacharya says, adding that it is difficult to tell exactly how much additional protection a booster shot would provide. This article was originally published in The Wall Street Journal.

Joe Gerald, MD, PhD, an associate professor of public health policy at the Mel and Enid Zuckerman College of Public Health and team leader for the UArizona COVID-19 modeling group joined The Show to talk more about Biden's vaccine mandate and the virus’ track in Arizona.

Some experts differ in their conclusions of whether a third shot is needed for recipients of the Pfizer-BioNTech and Moderna COVID-19 vaccines. Deepta Bhattacharya, PhD, an immunologist at the College of Medicine – Tucson said it’s normal for antibody levels to fall over the course of several months. Vaccination triggers a “blood-thirsty competition” among antibodies, he explained, and only the best ones survive ― “the antibodies that stick most tightly to the virus.”

The Arizona Bioindustry Association announced that Celebrating Life & Science, a one-hour broadcast event highlighting inspiring stories of Arizonans working together and using science to make life better for people everywhere will premiere on ABC15 on Sunday, Oct. 3. Janko Nikolich-Zugich, MD, PhD, department head of immunobiology at the College of Medicine – Tucson, will be featured as the Arizona Bioscience Researcher of the Year.

Former U.S surgeon general Dr. Richard Carmona takes on a new role as a senior adviser to the Arizona governor to boost vaccine and public health awareness.

Michael Grandner, PhD, the director of the Sleep and Health Research Program at the College of Medicine – Tucson, shares his expertise to help people get healthy sleep.

Two members of the Comprehensive Pain and Addiction Center are studying biological mechanisms of opioids in hopes of reducing negative side effects.

The Comprehensive Pain and Addiction Center will oversee the first peer support experiential learning and apprenticeship program in rural Arizona.